N/A
Manufactured by Laboratorios Quimica Son's, S.A. de C.V
6,474 FDA adverse event reports analyzed
Last updated: 2026-04-15
DEXPANTHENOL is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Laboratorios Quimica Son's, S.A. de C.V. The most commonly reported adverse reactions for DEXPANTHENOL include OFF LABEL USE, GASTROOESOPHAGEAL REFLUX DISEASE, SOMNOLENCE, PNEUMONIA ASPIRATION, COMA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for DEXPANTHENOL.
Out of 1,009 classified reports for DEXPANTHENOL:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.